Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Ian M, Franklin"'
Autor:
Mark R. Litzow, Anthony V. Moorman, Anthony H. Goldstone, Elisabeth Paietta, Gordon W. Dewald, Peter H. Wiernik, David I. Marks, Ian M. Franklin, Alan Kenneth Burnett, Martin S. Tallman, Hillard M. Lazarus, Adele K. Fielding, Selina M. Luger, Georgina Buck, Jacob M. Rowe, Susan M. Richards
The International ALL trial, conducted jointly by the MRC in the UK and ECOG in the US (UKALL XII/E2993), recruited 1929 patients between 1993 and 2006. All patients aged 16 to 64 years with newly diagnosed ALL, received the identical two phases of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76895345fd72bd2e5e7d5688a1dce4f2
https://ora.ox.ac.uk/objects/uuid:a215851c-0c2b-4bc3-bfa6-eb207002fb0d
https://ora.ox.ac.uk/objects/uuid:a215851c-0c2b-4bc3-bfa6-eb207002fb0d
Autor:
Selina M. Luger, David I. Marks, Susan M. Richards, Letizia Foroni, Gordon W. Dewald, Mark R. Litzow, Hillard M. Lazarus, Adele K. Fielding, I. Jill Durrant, Martin S. Tallman, Georgina Buck, Anthony H. Goldstone, Jacob M. Rowe, Elisabeth Paietta, Ian M. Franklin, Anthony V. Moorman, Andrew McMillan, Peter H. Wiernik
Prospective data on the value of allogeneic hematopoietic stem cell transplantation (alloHSCT) in Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL) are limited. The UKALLXII/ECOG 2993 study evaluated the outcome of assigning
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75fdffb428c20d97c365b80b3ee27f7f
https://ora.ox.ac.uk/objects/uuid:666c244b-6d06-4280-997f-d300ec3a0624
https://ora.ox.ac.uk/objects/uuid:666c244b-6d06-4280-997f-d300ec3a0624
Autor:
Hillard M. Lazarus, Georgina Buck, Susan M. Richards, Mark R. Litzow, R Chopra, Martin S. Tallman, Jacob M. Rowe, Jill Durrant, Peter H. Wiernik, Ian M. Franklin, Anthony H. Goldstone, H. Grant Prentice, Niculae Ciobanu, Alan Kenneth Burnett
The international acute lymphoblastic leukemia (ALL) study was designed to prospectively define the optimal therapy for adults 60 years of age or younger with newly diagnosed ALL. All patients received identical induction therapy, and 91% achieved co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c381cd355b28e2acaa436742d03106
https://ora.ox.ac.uk/objects/uuid:971d5bfc-5a3a-4ea9-a4f4-e97b444243e1
https://ora.ox.ac.uk/objects/uuid:971d5bfc-5a3a-4ea9-a4f4-e97b444243e1
Autor:
Martin S. Tallman, Peter H. Wiernik, Ian M. Franklin, Hillard J. Lazarus, H. G. Prentice, Alan Kenneth Burnett, Mark R. Litzow, G Harrison, Sue Richards, R Chopra, Jill Durrant, Jacob M. Rowe, Anthony H. Goldstone
In 1993 we initiated an International study in newly diagnosed adults with ALL (aged 15 to 55 years). 1508 eligible patients were entered before 31st October 2003 and achieved a complete remission (CR) rate of 91%. 551 patients underwent transplant i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b59e00279fc90a1decf9fbe8e3e974c0
https://ora.ox.ac.uk/objects/uuid:4a0bc2cb-4a88-43cb-850c-aff606b181e7
https://ora.ox.ac.uk/objects/uuid:4a0bc2cb-4a88-43cb-850c-aff606b181e7
Publikováno v:
Leukemia & Lymphoma. 49:2272-2283
Multiple myeloma (MM) is a clonal B-cell malignancy characterised by excess bone marrow plasma cells, serum and/or urine paraprotein, immune paraesis, renal failure and lytic bone lesions. Dendritic cells (DC) are key players in the adaptive and inna
Publikováno v:
Transfusion. 47:1172-1179
BACKGROUND: The use of a donation sample archive has been in place within the Scottish National Blood Transfusion Service for almost 35 years but the advent of human immunodeficiency virus donor testing led to this archive being kept for an indefinit
Autor:
Treen C. M. Morris, M. Robertson, Stewart J. Anderson, Richard E. Clark, Ian M. Franklin, N. P. Lucie, Gordon Cook, James Paul
Publikováno v:
British Journal of Haematology. 126:792-798
Whilst infusional vincristine, adriamycin and dexamethasone (VAD) is an effective treatment for patients with multiple myeloma (MM), administration may be complicated by line-associated infections and thromboses. The oral regime, Z-Dex (idarubicin an
Autor:
Rachel L. Harris, G. Reza Jalali, Frank Hill, Susan M. Richards, I. Jill Durrant, Ajay Vora, Christine J. Harrison, Tim O B Eden, Anthony H. Goldstone, Hazel M. Robinson, Zoë J. Broadfield, Kerry E. Barber, Sally E. Kinsey, M Martineau, Brenda Gibson, Ian Hann, Ian M. Franklin, Kan L. Cheung, Chris Mitchell, Anthony V. Moorman, John S. Lilleyman
Publikováno v:
British Journal of Haematology. 125:552-559
This study of children and adults with acute lymphoblastic leukaemia (ALL) is the largest series of patients with hypodiploidy (
Autor:
Lyndsay D. Mitchell, I. Grant McQuaker, Gordon Cook, P. Tansey, Anne Parker, Ian M. Franklin, Andrew Clark, Kenneth W. Douglas
Publikováno v:
British Journal of Haematology. 117:605-612
Summary. A phase I–II study of high-dose (HD) alkylating agents in newly diagnosed patients with multiple myeloma after maximum response to Z-Dex (idarubicin, dexamethasone) therapy and DHAP (cisplatin, HD cytosine arabinoside, dexamethasone), stem
Autor:
Nigel H. Russell, G. Miflin, Judith C. W. Marsh, R.M. Hutchinson, G. Cook, Donald Milligan, M.N. Potter, Gareth J. Morgan, A. Bell, Antonio Pagliuca, Ian M. Franklin
Publikováno v:
Cytotherapy. 2:423-428
PBSC are increasingly being used as the source of stem cells in allogeneic transplantation. An increased incidence of chronic GvHD has been suggested following unmanipulated allogeneic PBSC transplantation (PBSCT), however, how this affects overall s